Cancer professionals urge world leaders to attend U.N. meeting on NCDs

The American Society of Clinical Oncology (ASCO) on Monday sent a letter (.pdf) signed by major U.S. medical societies representing about 300,000 health care professionals to the White House urging President Barack Obama to participate in the U.N. High Level Meeting on Noncommunicable Diseases that is scheduled for September, Agence France-Presse reports. Leaders from world cancer organizations, speaking at a press conference at the 47th ASCO Annual Meeting in Chicago, urged Obama and other world leaders to attend the meeting to create a "broad international effort … to halt the rapid spread of cancer in poor and middle-income countries," the news service notes.

The oncologists also highlighted the "World Cancer Declaration," which outlines 11 goals they hope can be reached by 2020. "The goals, aimed at reducing levels of cancer, include sharp reductions in smoking, drinking alcohol, rates of obesity, and improvements in access to health care and universal vaccination programs for hepatitis B and human papillomavirus (HPV) aimed at preventing liver and uterine cancer," the news service writes (6/6).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine shows potential in preventing recurrence of triple-negative breast cancer